Earl Martin Douglas, General Counsel at BIOMIMETIC THERAPEUTICS, INC. (BMTI), sold 53,561 shares at $2.38 ($126K) on 2012-03-28, disclosed to the SEC on 2012-03-28.
Open-market sale of $126k BMTI by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 1,100 | $3K | 2.1% |
| 2 | $2.34 | 5,000 | $12K | 9.3% |
| 3 | $2.32 | 1,100 | $3K | 2.0% |
| 4 | $2.33 | 1,400 | $3K | 2.6% |
| 5 | $2.33 | 200 | $466 | 0.4% |
| 6 | $2.34 | 3,000 |
| $7K |
| 5.6% |
| 7 | $2.34 | 3,300 | $8K | 6.1% |
| 8 | $2.35 | 8,000 | $19K | 14.9% |
| 9 | $2.35 | 300 | $705 | 0.6% |
| 10 | $2.35 | 400 | $940 | 0.7% |
| 11 | $2.35 | 1,300 | $3K | 2.4% |
| 12 | $2.35 | 5,000 | $12K | 9.3% |
| 13 | $2.35 | 6,000 | $14K | 11.2% |
| 14 | $2.36 | 5,000 | $12K | 9.4% |
| 15 | $2.36 | 2,000 | $5K | 3.7% |
| 16 | $2.37 | 5,000 | $12K | 9.4% |
| 17 | $2.37 | 461 | $1K | 0.9% |
| 18 | $2.38 | 5,000 | $12K | 9.4% |
| Total | $2.35 avg | 53,561 | $126K | 100% |
| Filing → |
| ALLO | SELL | 2025-02-05 | $11K | — | Filing → |
| BMTI | SELL | 2011-10-14 | $27K | — | Filing → |
| BMTI | SELL | 2011-10-11 | $36K | — | Filing → |